Filed: Apr. 10, 2019
Latest Update: Apr. 10, 2019
Summary: ORDER GRANTING JOINT MOTION FOR TWO-DAY EXTENSION OF DEADLINE TO SUBMIT JOINT STATUS REPORT MIRANDA M. DU , District Judge . Pursuant to the Court's April 2, 2019 Order (ECF No. 194), Plaintiffs Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited (collectively, "Amarin"), Defendants Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals International Limited (collectively, "Hikma") and Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. (collectively,
Summary: ORDER GRANTING JOINT MOTION FOR TWO-DAY EXTENSION OF DEADLINE TO SUBMIT JOINT STATUS REPORT MIRANDA M. DU , District Judge . Pursuant to the Court's April 2, 2019 Order (ECF No. 194), Plaintiffs Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited (collectively, "Amarin"), Defendants Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals International Limited (collectively, "Hikma") and Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. (collectively, ..
More
ORDER GRANTING JOINT MOTION FOR TWO-DAY EXTENSION OF DEADLINE TO SUBMIT JOINT STATUS REPORT
MIRANDA M. DU, District Judge.
Pursuant to the Court's April 2, 2019 Order (ECF No. 194), Plaintiffs Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited (collectively, "Amarin"), Defendants Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals International Limited (collectively, "Hikma") and Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. (collectively, "DRL") in the above-referenced consolidated action were required to submit a joint status report within seven days of the Court's Order. Since the Court's April 2, 2019 Order, the parties have diligently worked on preparing proposals for the length of trial and the dates on which the parties are available for trial to be scheduled. As a result, the parties have narrowed their disputes related to trial length and scheduling, but request additional time to further narrow these disputes. The parties therefore respectfully request a two-day extension—to Thursday, April 11, 2019—of the deadline to submit the Joint Status Report.
IT IS SO ORDERED.
